The pharmaceutical landscape for diabetes is changing, and transdermal GLP-1 delivery systems represent a promising development. Unlike shots, this method offers a simpler way to administer GLP-1 therapies. These https://neiljibw552298.educationalimpactblog.com/62498276/glp-1-patches-a-novel-approach-to-blood-sugar-management